| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 16,334 | 78,723 | 79,809 | 80,690 | | Cost of Revenue | 3,821 | 80,190 | 83,952 | 75,302 | | | Gross Profit | 12,513 | (1,467) | (4,143) | 5,388 | | | Operating Expenses | | Research Development | (213) | 1,481 | 1,561 | 1,519 | | Selling General and Administrative | (7,460) | 7,318 | 7,267 | 7,267 | | Non Recurring | (4,719) | (1,075) | 10,028 | (4,234) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 24,905 | (9,191) | (22,999) | 836 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (713) | 914 | 1,924 | (210) | | Earnings Before Interest And Taxes | 24,192 | (8,277) | (21,075) | 626 | | Interest Expense | 1,111 | 1,604 | 1,350 | 1,492 | | Income Before Tax | 23,081 | (9,881) | (22,425) | (866) | | Income Tax Expense | (236) | (2,466) | (247) | (497) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 23,317 | (7,415) | (22,178) | (369) | | | Non-recurring Events | | Discontinued Operations | (58,142) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (34,825) | (7,415) | (22,178) | (369) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($34,825) | ($7,415) | ($22,178) | ($369) |
|
0.31% Nasdaq 
0.05%
Income Statement
